Goldman Sachs assumed coverage of Colgate-Palmolive with a Buy rating and $93 price target. The analyst believes the company’s commitment towards reinvestments has driven its turnaround, with global toothpaste market share gains for two consecutive years in a row, along with share gains in pet food globally, and personal care in Latin America and Europe. As such, the firm thinks Colgate is poised for healthy top-line growth momentum ahead.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive price target raised to $95 from $91 at Raymond James
- Colgate-Palmolive Welcomes Brian Newman to Board of Directors
- Colgate-Palmolive price target raised to $97 from $88 at Argus
- Colgate-Palmolive price target raised to $96 from $85 at Bernstein
- Colgate-Palmolive price target raised to $93 from $85 at Morgan Stanley